Loading company…
Orbion develops AI tools for protein research, engineering, and experimental protocol generation.
Orbion provides an AI-powered platform for protein characterization, engineering, and experimental protocol generation. It serves academic researchers and biopharmaceutical companies. Founded in 2025, the company is based in Berlin, Germany. In January 2025, it raised EUR 100,000 in pre-seed funding from Antler.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in